These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

942 related articles for article (PubMed ID: 23212421)

  • 21. Person-Specific Biomolecular Coronas Modulate Nanoparticle Interactions with Immune Cells in Human Blood.
    Ju Y; Kelly HG; Dagley LF; Reynaldi A; Schlub TE; Spall SK; Bell CA; Cui J; Mitchell AJ; Lin Z; Wheatley AK; Thurecht KJ; Davenport MP; Webb AI; Caruso F; Kent SJ
    ACS Nano; 2020 Nov; 14(11):15723-15737. PubMed ID: 33112593
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Nano-Bio Interactions in Cancer: From Therapeutics Delivery to Early Detection.
    Liu Y; Wang J; Xiong Q; Hornburg D; Tao W; Farokhzad OC
    Acc Chem Res; 2021 Jan; 54(2):291-301. PubMed ID: 33180454
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The Crown and the Scepter: Roles of the Protein Corona in Nanomedicine.
    Cai R; Chen C
    Adv Mater; 2019 Nov; 31(45):e1805740. PubMed ID: 30589115
    [TBL] [Abstract][Full Text] [Related]  

  • 24. In Situ Characterization of Protein Adsorption onto Nanoparticles by Fluorescence Correlation Spectroscopy.
    Shang L; Nienhaus GU
    Acc Chem Res; 2017 Feb; 50(2):387-395. PubMed ID: 28145686
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Corona Composition Can Affect the Mechanisms Cells Use to Internalize Nanoparticles.
    Francia V; Yang K; Deville S; Reker-Smit C; Nelissen I; Salvati A
    ACS Nano; 2019 Oct; 13(10):11107-11121. PubMed ID: 31525954
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Nanoparticle-Protein Interaction: The Significance and Role of Protein Corona.
    Ahsan SM; Rao CM; Ahmad MF
    Adv Exp Med Biol; 2018; 1048():175-198. PubMed ID: 29453539
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Silver nanoparticle protein corona and toxicity: a mini-review.
    Durán N; Silveira CP; Durán M; Martinez DS
    J Nanobiotechnology; 2015 Sep; 13():55. PubMed ID: 26337542
    [TBL] [Abstract][Full Text] [Related]  

  • 28. An in vitro release study of 5-fluoro-uracil (5-FU) from swellable poly-(2-hydroxyethyl methacrylate) (PHEMA) nanoparticles.
    Chouhan R; Bajpai AK
    J Mater Sci Mater Med; 2009 May; 20(5):1103-14. PubMed ID: 19132508
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Size-engineered biocompatible polymeric nanophotosensitizer for locoregional photodynamic therapy of cancer.
    Jeong K; Park S; Lee YD; Kang CS; Kim HJ; Park H; Kwon IC; Kim J; Park CR; Kim S
    Colloids Surf B Biointerfaces; 2016 Aug; 144():303-310. PubMed ID: 27107384
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Plasma protein adsorption and biological identity of systemically administered nanoparticles.
    Chen D; Ganesh S; Wang W; Amiji M
    Nanomedicine (Lond); 2017 Sep; 12(17):2113-2135. PubMed ID: 28805542
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Secreted biomolecules alter the biological identity and cellular interactions of nanoparticles.
    Albanese A; Walkey CD; Olsen JB; Guo H; Emili A; Chan WC
    ACS Nano; 2014 Jun; 8(6):5515-26. PubMed ID: 24797313
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Combinatory interpretation of protein corona and shear stress for active cancer targeting of bioorthogonally clickable gelatin-oleic nanoparticles.
    Meghani NM; Amin H; Park C; Cui JH; Cao QR; Choi KH; Lee BJ
    Mater Sci Eng C Mater Biol Appl; 2020 Jun; 111():110760. PubMed ID: 32279783
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Formation and characterization of the nanoparticle-protein corona.
    Monopoli MP; Pitek AS; Lynch I; Dawson KA
    Methods Mol Biol; 2013; 1025():137-55. PubMed ID: 23918335
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Recent advances in the engineering of nanosized active pharmaceutical ingredients: Promises and challenges.
    Kaialy W; Al Shafiee M
    Adv Colloid Interface Sci; 2016 Feb; 228():71-91. PubMed ID: 26792017
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Potential clinical applications of the personalized, disease-specific protein corona on nanoparticles.
    García Vence M; Chantada-Vázquez MDP; Vázquez-Estévez S; Manuel Cameselle-Teijeiro J; Bravo SB; Núñez C
    Clin Chim Acta; 2020 Feb; 501():102-111. PubMed ID: 31678275
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effect of nanoparticle size and PEGylation on the protein corona of PLGA nanoparticles.
    Partikel K; Korte R; Stein NC; Mulac D; Herrmann FC; Humpf HU; Langer K
    Eur J Pharm Biopharm; 2019 Aug; 141():70-80. PubMed ID: 31082511
    [TBL] [Abstract][Full Text] [Related]  

  • 37. How protein coronas determine the fate of engineered nanoparticles in biological environment.
    Capjak I; Goreta SŠ; Jurašin DD; Vrček IV
    Arh Hig Rada Toksikol; 2017 Dec; 68(4):245-253. PubMed ID: 29337683
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Species differences take shape at nanoparticles: protein corona made of the native repertoire assists cellular interaction.
    Hayashi Y; Miclaus T; Scavenius C; Kwiatkowska K; Sobota A; Engelmann P; Scott-Fordsmand JJ; Enghild JJ; Sutherland DS
    Environ Sci Technol; 2013 Dec; 47(24):14367-75. PubMed ID: 24245550
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Super-Resolution Microscopy Unveils Dynamic Heterogeneities in Nanoparticle Protein Corona.
    Feiner-Gracia N; Beck M; Pujals S; Tosi S; Mandal T; Buske C; Linden M; Albertazzi L
    Small; 2017 Nov; 13(41):. PubMed ID: 28922574
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Mathematical modeling of the protein corona: implications for nanoparticulate delivery systems.
    Dell'Orco D; Lundqvist M; Linse S; Cedervall T
    Nanomedicine (Lond); 2014 May; 9(6):851-8. PubMed ID: 24981650
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 48.